These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effects of Monobenzyl ether of hydroquinone on 3T3 mouse fibroblast viability and ultrastructure. Erdoğan A; Mutlu HS; Doğan S; Kotil T Ultrastruct Pathol; 2021 Nov; 45(6):384-390. PubMed ID: 34875974 [TBL] [Abstract][Full Text] [Related]
8. [Experimental depigmentation of black guinea pig skin. Comparative study of depigmentary action of monoethyl ether of hydroquinone and N-(mercaptoethyl-)-dimethylamine]. Frenk E Ann Dermatol Syphiligr (Paris); 1970; 97(3):287-96. PubMed ID: 5455227 [No Abstract] [Full Text] [Related]
9. [Exogenous ochronosis, a little-known side effect of hydroquinone-containing ointments]. Menke HE; Dekker SK; Noordhoek Hegt V; Pavel S; Westerhof W Ned Tijdschr Geneeskd; 1992 Jan; 136(4):187-90. PubMed ID: 1736131 [TBL] [Abstract][Full Text] [Related]
10. Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone). McGuinn KP; Saedi N; Green JB; Dover JS Dermatol Surg; 2019 May; 45(5):756-757. PubMed ID: 30893165 [No Abstract] [Full Text] [Related]
11. Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin. Bonchak JG; Eby JM; Willenborg KA; Chrobak D; Henning SW; Krzywiec A; Johnson SL; Le Poole IC Arch Biochem Biophys; 2014 Dec; 563():71-8. PubMed ID: 25132642 [TBL] [Abstract][Full Text] [Related]
12. [Experimental skin depigmentation. II. Epidermal reaction in external administration of depigmenting substances]. Wohlrab W; Zaumseil RP Dermatol Monatsschr; 1976 Dec; 162(12):980-5. PubMed ID: 1021476 [No Abstract] [Full Text] [Related]
14. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo]. Rojas-Urdaneta JE; Poleo-Romero AG Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541 [TBL] [Abstract][Full Text] [Related]
15. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133 [TBL] [Abstract][Full Text] [Related]
16. [Confetti-like dyschromia caused by a bleaching cream containing hydroquinone in racially pigmented patients]. Haas N Med Klin (Munich); 1988 May; 83(11):385-6, 390. PubMed ID: 3405155 [No Abstract] [Full Text] [Related]
17. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature. Mosher DB; Parrish JA; Fitzpatrick TB Br J Dermatol; 1977 Dec; 97(6):669-79. PubMed ID: 603749 [TBL] [Abstract][Full Text] [Related]
19. [Depigmentation for cosmetic purposes: prevalence and side-effects in a female population in Senegal]. Raynaud E; Cellier C; Perret JL Ann Dermatol Venereol; 2001; 128(6-7):720-4. PubMed ID: 11460033 [TBL] [Abstract][Full Text] [Related]
20. Monobenzone, Superfade, vitiligo and confetti-like depigmentation. Catona A; Lanzer D Med J Aust; 1987 Mar; 146(6):320-1. PubMed ID: 3821640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]